Five participants (0.8%) in the Paxlovid group and 10 (1.6%) in the placebo group were hospitalized for Covid-19 or died from any cause. The time to sustained alleviation of all signs and symptoms ...

THURSDAY, March 6, 2025 (HealthDay News) -- The antiviral drug Paxlovid may not offer much protection against COVID-related hospitalizations or deaths for vaccinated older adults after all.